Additionally, four lncRNAs were described as downregulated (e.g., LET, GCASPC, and MEG3), also acting as agents whose low expression promotes malignant tumor characteristics in these patients, worsening the overall survival (OS) in these patients. The gene discussed is MEG3; the disease is cancer.